Does Pharma 'Highjack' FDA Public Comment on C... - CLL Support

CLL Support

22,987 members39,473 posts

Does Pharma 'Highjack' FDA Public Comment on Cancer Drugs?

Cllcanada profile image
CllcanadaTop Poster CURE Hero
4 Replies

About one-third of "public" speakers at US Food and Drug Administration (FDA) advisory committee meetings on yet-to-be-approved cancer drugs in recent years had financial ties to the pharmaceutical industry, according to new research.

In other words, public testimony, which is mostly from patients and the staff of nonprofits, and can be emotionally compelling, is regularly supported by private interests.

"Some of the stories are really compelling," Dr Prasad said, "but it's a mistake to assume that people who speak at these hearings represent the average patient or express what the average patient wants."

"We're likely hearing more of the upsides. Patients who suffered real side effects — they are not the ones able to travel to these meetings," he added.

Medscape Article..free to get an account...

medscape.com/viewarticle/85...

Written by
Cllcanada profile image
Cllcanada
Top Poster CURE Hero
To view profiles and participate in discussions please or .
4 Replies
virdieblue profile image
virdieblue

And I read recently that the Lymphoma and Leukemia Society gets 60% of its funding from big pharma. Might not be receptive to drug pricing discussions.

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to virdieblue

Can you provide a source? How has this effected drug pricing? The Medicare bill specifically prevents drug price negotiations... start with your law makers...

congress.gov/bill/114th-con...

statnews.com/2016/01/06/med...

statnews.com/2015/12/01/sta...

Couple this with the Orphan Drug Act... closed markets... no free enterprise, patents run 15 years... perks, public funded research/clinical trials and tax breaks...

en.m.wikipedia.org/wiki/Orp...

Certainly the LLS partners with pharma under a number of projects, including TAP

lls.org/therapy-acceleratio...

The LLS helps thousands of CLL patients with copayment relief, so they can afford the new very expensive treatments like Imbruvica (ibrutinib), Idelalisib (Zydelig) and Gazyva (obinutuzumab)...

~chris

virdieblue profile image
virdieblue in reply to Cllcanada

It was in my local Sunday paper. I'll try try to track it down.

LLS does good things, and Im a contributer, but maybe in this area not so good?

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to virdieblue

It is not in their mandate to negotiate drug costs... in the U.S. it is congress or private insurers...

Not what you're looking for?

You may also like...

Update for UK FLAIR Study Participants who have come to the end of 6 years of Ibrutininb treatment.

Many patients were fortunate to receive Ibrutinib as their first treatment in the UK FLAIR study...

Open letter from cancer charities to the public regarding vulnerable members of our communities in UK

This is the open letter which has been signed by forty UK charities including six blood cancer...

Cancer Lottery - campaign asking for fair consideration of new drugs required to treat rarer cancer patients in the UK

Many will have been following the unsatisfactory way in which new drugs for CLL are being assessed...

Good article on navigating complementary cancer treatments

I'm sharing this link to what I consider a balanced and helpful recent article about how persons...

CLLSA and Leukaemia Care Joint Response to NHS England regarding Ibrutinib Prescribing as per NICE TA

This is the letter sent to Professor Peter Clarke on 2nd July 2018 for the review of Ibrutinib...